ReviewAdvances in rheumatology (London, England)2024

Targeting Bruton's tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments.

Gita Manzari Tavakoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.